wetzoeker

S4.3 — AGENTS PREVENTING ACTIVIN RECEPTOR IIB ACTIVATION Internationaal Verdrag tegen doping in de sport

AGENTS PREVENTING ACTIVIN RECEPTOR IIB ACTIVATION

Including, but not limited, to:

Activin A-neutralising antibodies

Activin receptor IIB competitors such as:

– Decoy activin receptors (e.g. ACE-031)

Anti-activin receptor IIB antibodies (e.g. bimagrumab)

Myostatin inhibitors such as:

– Agents reducing or ablating myostatin expression

– Myostatin-binding proteins (e.g. follistatin, myostatin propeptide)

– Myostatin- or precursor-neutralising antibodies (e.g. apitegromab, domagrozumab, landogrozumab, stamulumab)

Regeling
Internationaal Verdrag tegen doping in de sport
Soort
Verdrag
Geldend vanaf
01-01-2026
BWB-id
BWBV0001829
Versie
2026-01-01_0

In de hele regeling · Officiële tekst op wetten.overheid.nl